Brom, Martin http://orcid.org/0000-0003-3960-3741
Moyano, Sebastian http://orcid.org/0000-0001-5100-9513
Gandino, Ignacio J. http://orcid.org/0000-0003-3540-6169
Scolnik, Marina http://orcid.org/0000-0002-0542-8001
Soriano, Enrique R. http://orcid.org/0000-0003-3143-1084
Article History
Received: 19 April 2019
Accepted: 22 August 2019
First Online: 30 August 2019
Compliance with ethical standards
:
: Martin Brom declares that he has no conflict of interest. Sebastian Moyano declares that he has no conflict of interest. Ignacio Javier Gandino declares that he has no conflict of interest. Marina Scolnik declares that she has no conflict of interest. Enrique Roberto Soriano reports grants and personal fees from Roche, grants and personal fees from Novartis, grants and personal fees from Abbvie, grants and personal fees from Glaxo, personal fees from Pfizer, personal fees from Lilly, personal fees from Sanofi, personal fees from AMGEN, personal fees from Bristol Myers Squibb, personal fees from Genzyme, outside the submitted work. All listed authors meet the ICMJE 4 criteria for authorship and have approved the final manuscript. All co-authors take full responsibility for the integrity of the study and the final manuscript. This study has been presented in the 2018 PANLAR meeting, abstract #38 (Brom M, Moyano S, Scolnik M, Gandino JI, Soriano ER (2018) Incidence of Cancer in a cohort of patients with primary Sjögren syndrome. Abstracts, 20th PANLAR Meeting. JCR J Clin Rheumatol 24:S1–S174. ExternalRef removed), and in the 2017 ACR meeting, abstract #1483 (Brom M, Moyano S, Scolnik M, Soriano ER (2017) Incidence of Cancer in a Cohort of Patients with Primary Sjögren Syndrome [abstract]. 2017 ACR/ARHP Annual Meeting Abstract Supplement. Arthritis Rheumatol 69:1–4481. ExternalRef removed).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: IRB00010193, protocol number #5141, <i>Comité de Ética de Protocolos de Investigación del Hospital Italiano de Buenos Aires</i>).
: Patients sign a general informed consent on their first visit to our institution, authorizing the use of their medical data in an anonymized way for retrospective studies.